Gardasil's use in men intensifies vaccine debate

03/27/2009 | Washington Post (tiered subscription model), The

The debate over whether cervical cancer vaccine Gardasil will cause an increase in sexual activity among teenage girls has shifted to whether the vaccine is safe and cost-effective in protecting boys against genital warts and other cancers that can be triggered by human papillomavirus. The change in discussion comes as Merck & Co. awaits FDA approval to promote the use of Gardasil in males ages 9 to 26.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA